https://www.selleckchem.com/pr....oducts/guanidine-thi
0 years with corresponding LMEs of US$ 73,791, 79,496, 89,962, and 66,981, respectively. The difference in LE between stages I and IV was 26.2 years while that of loss-of-LE was 23.8 years, which implies that a potential lead time bias may exist if diagnosis at younger ages for earlier stages were not adjusted for. The ICER of mammography seemed cost-saving after the coverage exceeded half a million. Mammography could detect BC early and be cost-saving after adjustment for different distributions of age and calendar year o
Like
Comment
Share
